Indolinone protein kinase inhibitors and cyclooxygenase inhibitors for use in combination therapy for the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7320996
APP PUB NO 20030216410A1
SERIAL NO

10218910

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to methods for treatment or prevention of neoplasia disorders using protein tyrosine kinase inhibitors of the formula I: ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, and R.sup.7 are defined herein, in combination with cyclooxygenase inhibitors, in particular cyclooxygenase-2 selective inhibitors.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHARMACIA CORPORATION800 N LINDBERGH BLVD ST LOUIS MO 63167
SUGEN INC230 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cherrington, Julie San Francisco, CA 4 96
Doshi, Parul Wildwood, MO 14 245
Masferrer, Jaime Ballwin, MO 7 154

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation